Tilray Inc Market Cap ($321.85 Million)
Market Cap & Net Worth: Tilray Inc (TLRY)
Tilray Inc market cap. Tilray Inc (TO:TLRY) has a market capitalization of $321.85 Million (CA$444.93 Million) as of November 4, 2026. Listed on the TO stock exchange, this Canada-based company holds position #14170 globally and #420 in its home market, demonstrating a -2.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tilray Inc's stock price CA$3.72 by its total outstanding shares 119604223 (119.60 Million). Also see Tilray Inc (TLRY) cash flow conversion for how efficiently the company converts equity into cash flow.
Tilray Inc Market Cap History (2021–2026)
Tilray Inc market cap history from 2021 to 2026. Data shows change from $771.76 Million to $321.85 Million (-25.91% CAGR). Check today's stock price for Tilray Inc for real-time trading data and today's change.
Index Memberships
Tilray Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P TSX Composite Index (Canada)
GSPTSE
|
$3.87 Trillion | 0.01% | #206 of 225 |
Weight: Tilray Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tilray Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tilray Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore TLRY net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.31x
Tilray Inc's market cap is 1.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $771.76 Million | $513.09 Million | -$336.01 Million | 1.50x | N/A |
| 2022 | $317.53 Million | $628.37 Million | -$434.13 Million | 0.51x | N/A |
| 2023 | $264.75 Million | $627.12 Million | -$1.44 Billion | 0.42x | N/A |
| 2024 | $164.39 Million | $788.94 Million | -$244.98 Million | 0.21x | N/A |
| 2025 | $1.07 Billion | $821.31 Million | -$2.19 Billion | 1.31x | N/A |
Competitor Companies of TLRY by Market Capitalization
Companies near Tilray Inc in the global market cap rankings as of November 4, 2026. Also see Tilray Inc (TLRY) total assets for a full breakdown of the balance sheet.
Key companies related to Tilray Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Tilray Inc (2021–2026)
Market capitalization of Tilray Inc from 2021 to today. Between 2021 and today, Tilray Inc's market cap moved from $771.76 Million to $ 321.85 Million, with a yearly change of -25.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$321.85 Million | -70.02% |
| 2025 | CA$1.07 Billion | +553.16% |
| 2024 | CA$164.39 Million | -37.91% |
| 2023 | CA$264.75 Million | -16.62% |
| 2022 | CA$317.53 Million | -58.86% |
| 2021 | CA$771.76 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Tilray Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $321.85 Million USD |
| MoneyControl | $321.85 Million USD |
| MarketWatch | $321.85 Million USD |
| marketcap.company | $321.85 Million USD |
| Reuters | $321.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more